dc.creatorLula, Ivana
dc.creatorDe Sousa, Frederico B.
dc.creatorDenadai, Angelo M. L.
dc.creatorde Lima, Guilherme Ferreira
dc.creatorDuarte, Helio Anderson
dc.creatordos Mares Guia, Thiago R.
dc.creatorFaljoni-Alario, Adelaide
dc.creatorSantoro, Marcelo M.
dc.creatorde Camargo, Antonio C. M.
dc.creatordos Santos, Robson A. S.
dc.creatorSinisterra, Ruben D.
dc.date.accessioned2013-10-29T13:05:45Z
dc.date.accessioned2018-07-04T16:09:42Z
dc.date.available2013-10-29T13:05:45Z
dc.date.available2018-07-04T16:09:42Z
dc.date.created2013-10-29T13:05:45Z
dc.date.issued2013-08-02
dc.identifierMATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, AMSTERDAM, v. 32, n. 2, supl. 1, Part 3, pp. 244-253, 36951, 2012
dc.identifier0928-4931
dc.identifierhttp://www.producao.usp.br/handle/BDPI/36305
dc.identifier10.1016/j.msec.2011.10.025
dc.identifierhttp://dx.doi.org/10.1016/j.msec.2011.10.025
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1632235
dc.description.abstractHerein, we demonstrate the physical and chemical characterizations of the supramolecular complex formed between beta-cyclodextrin (beta CD) and bradykinin potentiating nonapeptide (BPP9a), an endogenous toxin found in Bothrops jararaca. Circular dichroism results indicate a conformational change in the BPP9a secondary structure upon its complexation with beta CD. Nuclear magnetic resonance results, mainly from NOESY experiments, and theoretical calculations showed a favorable interaction between the tryptophan residue of BPP9a and the beta CD cavity. Thermodynamic inclusion parameters were investigated by isothermal titration calorimetry, demonstrating that beta CD/BPP9a complex formation is an exothermic process that results in a reduction in entropy. Additionally, in vitro degradation study of BPP9a against trypsin (37 degrees C, pH 7.2) showed higher stability of peptide in presence of beta CD. This beta CD/BPP9a complex, which presents new chemical properties arising from the peptide inclusion process, may be useful as an antihypertensive drug in oral pharmaceutical formulations. (C) 2011 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCIENCE BV
dc.publisherAMSTERDAM
dc.relationMATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
dc.rightsCopyright ELSEVIER SCIENCE BV
dc.rightsclosedAccess
dc.subjectBRADYKININ POTENTIATING PEPTIDES
dc.subjectACE INHIBITORS
dc.subjectANTI-HYPERTENSIVE ACTIVITY
dc.subjectBETA-CYCLODEXTRIN
dc.titleInteraction between bradykinin potentiating nonapeptide (BPP9a) and beta-cyclodextrin: A structural and thermodynamic study
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución